
Opinion|Videos|May 28, 2025
Screening and Managing Comorbidities for Patients With Duchenne Muscular Dystrophy
Author(s)Diana Castro, MD
Explore the comprehensive comorbidities of Duchenne Muscular Dystrophy, including cognitive, respiratory, and nutritional challenges faced by patients.
Advertisement
Episodes in this series

Summary for Physicians
Common Comorbidities in Duchenne Muscular Dystrophy (DMD)
Patients with DMD patients often experience a wide range of comorbidities that require ongoing monitoring and management. These include the following:
- Cognitive and Behavioral Issues
- Affects around 1/3 of patients, presenting as autism, attention-deficit/hyperactivity disorder, learning difficulties, and behavioral challenges.
- Ophthalmologic Concerns
- Annual ophthalmology checkups are recommended due to the risk of cataracts from steroid use.
- Swallowing and Respiratory Issues
- Difficulty in swallowing develops later, but respiratory muscle weakness (diaphragm and intercostal muscles) can cause restrictive lung disease and obstructive sleep apnea.
- Cardiac Issues
- Cardiomyopathy can be detected early, with studies showing changes in cardiac MRI at 10 years old or younger in 17% of patients.
- Gastrointestinal and Urinary Complications
- Common issues include reflux, constipation, urinary urgency, and retention, with kidney stones also a concern in adults due to low water intake.
- Orthopedic Problems
- Patients often develop contractures (ankles, knees, hips, elbows, hands) and scoliosis, though the latter is less common due to steroid use. Some patients may still develop scoliosis in adulthood, requiring surgery.
- Psychological Problems
- Depression, anxiety, and obsessive-compulsive disorder behaviors are common in this population.
Comorbidity Screening Approach
A multidisciplinary approach is crucial for effective care, focusing on early detection and management:
- Neurological Screening
- As a neurologist, I screen for motor and cognitive issues and make referrals to specialists when needed (e.g.eg, gastroenterologists, endocrinologists).
- Cardiological Monitoring
- Regular electrocardiograms, echocardiograms, and cardiac MRIs are essential. Early intervention with medications can prevent cardiac deterioration.
- Pulmonary Function Testing
- Pulmonologists and respiratory therapists perform pulmonary function tests, which are most reliable after 5 years of age.
- Nutrition Support
- Nutritionists monitor and manage obesity (a significant issue due to steroids) by promoting a low-carb, low-fat, low-sugar diet and providing vitamin D and B12 supplements. Regular lab work includes lipid profiles and vitamin testing.
- Physical and Occupational Therapy
- Standardized tests, such as North Star and 10-meter walk/run, help track motor function and progression, guiding equipment needs.
Advertisement
Related to this article

Carmela Tartaglia, MD, FRCPC, discusses the challenges of diagnosing frontotemporal dementia, the evolving role of biomarkers, and emerging approaches to disease modification.

Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.

Newly announced Phase 4 THRIVE trial results showed most patients who previously had an inadequate response to a CGRP-targeting therapy improved with eptinezumab over 24 weeks.

Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.

New cerebrospinal fluid biomarker data suggest shared LRRK2 pathway activation across sporadic and LRRK2-associated Parkinson disease, potentially informing biomarker development and therapeutic targeting.

An MDS 2026 plenary speaker discusses the evolving role of infusion therapies, deep brain stimulation, and focused ultrasound in Parkinson disease, including when to consider device-aided therapies and how treatment selection can be individualized.

Mitzi Joi Williams, MD, is joined by Jakai McEwen, DO, and Charnetta Colton-Poole, MD, to discuss the challenges of communication between patients and their health care teams, including navigating medical language, promoting shared decision-making, and advocating for clear, patient-centered care.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease
2
CSF Biomarkers Identify Shared LRRK2 Pathway Activation in Sporadic and LRRK2-Associated Parkinson Disease
3
Phase 4 THRIVE Data Highlights Eptinezumab’s Impact on Migraine After Prior CGRP Failure
4
Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches
5



